Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155712 · ClinicalTrials.gov registry record · NA
Triathlon Tritanium Knee Outcomes Study
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 680
- Enrollment target
NCT02155712 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 680 participants.
The verdict
NCT02155712, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 680 participants
- Enrollment target
Study Summary
The success of the Triathlon Tritanium Knee will be determined by comparing the rate of absence of revision for aseptic loosening of the tibial baseplate at 2 years with the rates reported in the literature.
Interventions
- DEVICE Triathlon Tritanium Knee
- DEVICE Triathlon Knee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 680 participants |
| Start Date | 2014-10 |
| Est. Completion | 2023-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02155712
The ClinicalTrials.gov registry entry for NCT02155712 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 680 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Triathlon Tritanium Knee is the first listed.
NCT02155712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02155712 about?
NCT02155712 is a clinical study titled "Triathlon Tritanium Knee Outcomes Study". The success of the Triathlon Tritanium Knee will be determined by comparing the rate of absence of revision for aseptic loosening of the tibial baseplate at 2 years with the rates reported in the literature.
What is the current status of trial NCT02155712?
This trial is currently terminated. It is a NA study. The enrollment target is 680 participants. The study started on 2014-10. Estimated completion is 2023-03-11.
What interventions are being tested in trial NCT02155712?
The interventions under investigation include: Triathlon Tritanium Knee (DEVICE), Triathlon Knee (DEVICE).
Who is sponsoring clinical trial NCT02155712?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.